Your browser doesn't support javascript.
loading
The Current State of NAD+ -Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets.
Schiedel, Matthias; Robaa, Dina; Rumpf, Tobias; Sippl, Wolfgang; Jung, Manfred.
Afiliação
  • Schiedel M; Institute of Pharmaceutical Sciences, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
  • Robaa D; Department of Pharmaceutical Chemistry, Martin-Luther Universität Halle-Wittenberg, Halle/Saale, Germany.
  • Rumpf T; Institute of Pharmaceutical Sciences, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
  • Sippl W; Department of Pharmaceutical Chemistry, Martin-Luther Universität Halle-Wittenberg, Halle/Saale, Germany.
  • Jung M; Institute of Pharmaceutical Sciences, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
Med Res Rev ; 38(1): 147-200, 2018 01.
Article em En | MEDLINE | ID: mdl-28094444
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Histona Desacetilases do Grupo III / Inibidores de Histona Desacetilases Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Histona Desacetilases do Grupo III / Inibidores de Histona Desacetilases Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article